VIKING GLOBAL INVESTORS LP sold 77.3% of their position (350K shares) of INHIBRX BIOSCIENCES, INC. on the open market
Open‑market sale worth $11.29M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 10/9/2025ACC: 0000905148-25-003555
10% Owner
Since May 2024
-350K
Net shares
Net seller
$11.29M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
350K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−308.64K
Price / share
$32.25
Trade value
$9.95M
% of position
19.6%
10/7/2025
1.58M→1.27M
Common Stock
Indirect
Shares
−16.32K
Price / share
$32.25
Trade value
$526.16K
% of position
19.6%
10/7/2025
83.33K→67.02K
Common Stock
Indirect
Shares
−25.04K
Price / share
$32.25
Trade value
$807.60K
% of position
19.6%
10/7/2025
127.91K→102.86K
Total
Net shares
−350K
Net value
-$11.29M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/7/2025 | S · Sale | −308.64K | $32.25 | $9.95M | 19.6% | 1.58M | 1.27M |
| Common Stock Indirect | 10/7/2025 | S · Sale | −16.32K | $32.25 | $526.16K | 19.6% | 83.33K | 67.02K |
| Common Stock Indirect | 10/7/2025 | S · Sale | −25.04K | $32.25 | $807.60K | 19.6% | 127.91K | 102.86K |
| Total | −350K | -$11.29M | ||||||
Derivative Transactions0
No derivative transactions reported